Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Tanner

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cell Death & Disease|October 21, 2016
Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblastsRajeev B Tajhya, Xueyou Hu, Mark R Tanner, et al.
The Journal of Biological Chemistry|March 20, 2014
Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthmaShyny Koshy, Redwan Huq, Mark R Tanner, et al.
Scientific Reports|March 29, 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseasesM Harunur Rashid, Redwan Huq, Mark R Tanner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2020
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9Ang Li, Mark R Tanner, Ciaran M Lee, et al.
Antioxidants (Basel, Switzerland)|October 21, 2020
Antioxidant Carbon Nanoparticles Inhibit Fibroblast-Like Synoviocyte Invasiveness and Reduce Disease Severity in a Rat Model of Rheumatoid ArthritisMark R Tanner, Redwan Huq, William K A Sikkema, et al.
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Scientific Reports|September 23, 2016
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulationRedwan Huq, Errol L G Samuel, William K A Sikkema, et al.
Leukemia|March 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamidePortia Smallbone, Kai Cao, Rima M Saliba, et al.
Transplantation and Cellular Therapy|August 8, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple MyelomaOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Transplantation and Cellular Therapy|October 24, 2024
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17pCurtis Marcoux, Oren Pasvolsky, Denái R Milton, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|October 21, 2016
Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblastsRajeev B Tajhya, Xueyou Hu, Mark R Tanner, et al.
The Journal of Biological Chemistry|March 20, 2014
Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthmaShyny Koshy, Redwan Huq, Mark R Tanner, et al.
Scientific Reports|March 29, 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseasesM Harunur Rashid, Redwan Huq, Mark R Tanner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2020
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9Ang Li, Mark R Tanner, Ciaran M Lee, et al.
Antioxidants (Basel, Switzerland)|October 21, 2020
Antioxidant Carbon Nanoparticles Inhibit Fibroblast-Like Synoviocyte Invasiveness and Reduce Disease Severity in a Rat Model of Rheumatoid ArthritisMark R Tanner, Redwan Huq, William K A Sikkema, et al.
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Scientific Reports|September 23, 2016
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulationRedwan Huq, Errol L G Samuel, William K A Sikkema, et al.
Leukemia|March 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamidePortia Smallbone, Kai Cao, Rima M Saliba, et al.
Transplantation and Cellular Therapy|August 8, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple MyelomaOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Transplantation and Cellular Therapy|October 24, 2024
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17pCurtis Marcoux, Oren Pasvolsky, Denái R Milton, et al.
Pageof 5